The effects of GnRH antagonist on the endometrium of normally menstruating women

Journal of Assisted Reproduction and Genetics

Volumn 24, Issue 12, 2007, Pages 579-586

  Sirayapiwat, Porntip ^a   Suwajanakorn, Somchai ^a   Triratanachat, Surang ^a   Niruthisard, Somchai ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Endometrium; GnRH antagonist; Histological dating; Morphometric analysis

Indexed keywords

ESTRADIOL; GANIRELIX;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ESTRADIOL BLOOD LEVEL; FEMALE; HISTOPATHOLOGY; HUMAN; MEASUREMENT; MORPHOMETRICS; MULTIPLE CYCLE TREATMENT; OVULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF CONTROL; STATISTICAL ANALYSIS; TREATMENT DURATION;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIUM; ESTRADIOL; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEINIZING HORMONE; MENSTRUAL CYCLE; OVULATION;

EID: 38549151295     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10815-007-9184-z     Document Type: Article

References (37)

1. Daya S. Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles. Cochrane Database Syst Rev 2000;2:CD001299.
2. Olivennes F, Cunha-Filho JS, Fanchin R, Bouchard P, Frydman R. The use of GnRH antagonists in ovarian stimulation. Hum Reprod Update 2002;8:279-90.
3. Newton C, Slota D, Yuzpe AA, Tummon IS. Memory complaints associated with the use of gonadotropin-releasing hormone agonists: a preliminary study. Fertil Steril 1996;65:1253-5.
4. Warnock JK, Bundren JC, Morris DW. Depressive mood symptoms associated with ovarian suppression. Fertil Steril 2000;74:984-6.
5. Shapiro DB. Introduction. Fertil Steril 2003;80(suppl 1):S1-7.
6. The North American Ganirelix Study Group. Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil Steril 2001;75:38-45.
7. The European Orgalutran. Treatment with the gonadotropin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe, and convenient: results of a controlled, randomized, multicentre trial. Hum Reprod 2000;15:1490-8.
8. The European and Middle East Orgalutran. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod 2001;16:644-51.
9. Albano C, Felberbaum RE, Smitz J, Riethmüller-Winzen H, Engel J, Diedrich K, et al. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. Hum Reprod 2000;15:526-31.
10. Olivennes F, Belaisch-Allart J, Emperaire JC, Dechuad H, Alvarez S, Moreau L, et al. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). Fertil Steril 2000;73:314-20.
11. Al-Inany H, Aboulghar M. GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod 2002;17:874-85.
12. Al-Inany H, Abou-Setta AM, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database Syst Rev 2006;3:CD001750.
13. Nikolettos N, Al-Hasani S, Felberbaum R, Demirel LC, Riethmüller- Winzen H, Reissmann T, et al. Comparison of cryopreservation outcome with human pronuclear stage oocytes obtained by the GnRH antagonist, Cetrorelix, and GnRH agonists. Eur J Obstet Gynaecol Reprod Biol 2000;93:91-5.
14. Seelig AS, Al-Hasani S, Katalinic A, Schöpper B, Sturm R, Diedrich K, et al. Comparison of cryopreservation outcome with gonadotropin-releasing hormone agonists or antagonists in the collecting cycle. Fertil Steril 2002;77:472-5.
15. Kol S, Lightman A, Hillensjo T, Devroey P, Fauser B, Tarlatzis B, et al. High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles. Hum Reprod 1999;14:2242-4.
16. Hernandez ER. Embryo implantation and GnRH antagonists: Embryo implantation: the Rubicon for GnRH antagonists. Hum Reprod 2000;15:1211-6.
17. Dong KW, Marcelin K, Hsu MI, Chiang CM, Hoffman G, Roberts JL. Expression of gonadotropin-releasing hormone (GnRH) gene in human uterine endometrial tissue. Mol Hum Reprod 1998;4:893-8.
18. Raga F, Casan EM, Kruessel JS, Wen Y, Huang HY, Nezhat C, et al. Quantitative gonadotropin-releasing hormone gene expression and immunohistochemical localization in human endometrium throughout the menstrual cycle. Biol Reprod 1998;59:661-9.
19. Takeuchi S, Futamura N, Minoura H, Toyoda N. Possible direct effect of gonadotropin releasing hormone on human endometrium and decidua. Life Sci 1998;62:1187-94.
20. Acosta AA, Elberger L, Borghi M, Calamera JC, Chemes H, Doncel GF, et al. Endometrial dating and determination of the window of implantation in healthy fertile women. Fertil Steril 2000;73:788-98.
21. Li TC, Lenton EA, Rogers AW, Cooke ID, Dockery P. A new method of histologic dating of human endometrium in the luteal phase. Fertil Steril 1988;50:52-60.
22. Bakos O, Lundkvist Ö, Wide L, Bergh T. Ultrasonographical and hormonal description of the normal ovulatory menstrual cycle. Acta Obstet Gynecol Scand 1994;73:790-6.
23. Ritchie WGM. Ultrasound in the evaluation of normal and induced ovulation. Fertil Steril 1985;43:167-81.
24. Ecochard R, Boehringer H, Rabilloud M, Marret H. Chronological aspects of ultrasonic, hormonal, and other indirect indices of ovulation. Br J Obstet Gynaecol 2001;108:822-9.
25. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950;1:3-25.
26. Johannisson E, Parker RA, Landgren BM, Diczfalusy E. Morphometric analysis of the human endometrium in relation to peripheral hormone levels. Fertil Steril 1982;38:564-71.
27. Sereepapong W, Suwajanakorn S, Triratanachat S, Sampatanukul P, Pruksananonda K, Boonkasemsanti W, et al. Effects of clomiphene citrate on the endometrium of regularly cycling women. Fertil Steril 2000;73:287-91.
28. Fauser B, Devroey P. Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow? Fertil Steril 2005;83:1607-11.
29. Griesinger G, Felderbaum R, Diedrich K. GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German national IVF registry. Hum Reprod 2005;20:2373-5.
30. The ganirelix dose-finding study group. A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotropin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon®). Hum Reprod 1998;13:3023-31.
31. Kolibianakis E, Bourgain C, Albano C, Osmanagaoglu K, Smitz J, Van Steirteghem A, et al. Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertil Steril 2002;78:1025-9.
32. Saadat P, Boostanfar R, Slater CC, Tourgeman DE, Stanczyk FZ, Paulson RJ. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists. Fertil Steril 2004;82:167-71.
33. Griesinger G, Felberbaum RE, Schultze-Mosgau A, Diedrich K. Gonadotropin-releasing hormone antagonists for assisted reproductive techniques: are there clinical differences between agents? Drugs 2004;64:563-75.
34. Oberyé JJL, Mannaerts BMJL, Huisman JAM, Timmer CJ. Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon®/Orgalutran®). Part II. Dose-proportionality and gonadotropin suppression after multiples doses of ganirelix in healthy female volunteers. Fertil Steril 1999;72:1006-12.
35. Ueno J, Oehninger S, Brzyski RG, Acosta AA, Philput CB, Muasher SJ. Ultrasonographic appearance of the endometrium in natural and stimulated in-vitro fertilization cycles and its correlation with outcome. Hum Reprod 1991;6:901-4.
36. Ohno Y, Hosokawa K, Tamura T, Fujimoto Y, Kawashima M, Koishi K, et al. Endometrial oestrogen and progesterone receptors and their relationship to sonographic appearance. Hum Reprod 1995;10:708-11.
37. Ollendorff DA, Fejgin MD, Barzilai M, Ben-Noon I, Gerbie AB. The value of curettage in the diagnosis of ectopic pregnancy. Am J Obstet Gynecol 1987;157:71-2.